IBDEI1F2 ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,22912,0)
;;=L43.2^^76^987^16
;;^UTILITY(U,$J,358.3,22912,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22912,1,3,0)
;;=3^Lichenoid Drug Reaction
;;^UTILITY(U,$J,358.3,22912,1,4,0)
;;=4^L43.2
;;^UTILITY(U,$J,358.3,22912,2)
;;=^5009180
;;^UTILITY(U,$J,358.3,22913,0)
;;=L43.9^^76^987^13
;;^UTILITY(U,$J,358.3,22913,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22913,1,3,0)
;;=3^Lichen Planus,Unspec
;;^UTILITY(U,$J,358.3,22913,1,4,0)
;;=4^L43.9
;;^UTILITY(U,$J,358.3,22913,2)
;;=^5009183
;;^UTILITY(U,$J,358.3,22914,0)
;;=L93.0^^76^987^18
;;^UTILITY(U,$J,358.3,22914,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22914,1,3,0)
;;=3^Lupus,Erythematosus,Discoid
;;^UTILITY(U,$J,358.3,22914,1,4,0)
;;=4^L93.0
;;^UTILITY(U,$J,358.3,22914,2)
;;=^5009467
;;^UTILITY(U,$J,358.3,22915,0)
;;=L93.2^^76^987^20
;;^UTILITY(U,$J,358.3,22915,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22915,1,3,0)
;;=3^Lupus,Erythematosus,Local
;;^UTILITY(U,$J,358.3,22915,1,4,0)
;;=4^L93.2
;;^UTILITY(U,$J,358.3,22915,2)
;;=^5009469
;;^UTILITY(U,$J,358.3,22916,0)
;;=L93.1^^76^987^21
;;^UTILITY(U,$J,358.3,22916,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22916,1,3,0)
;;=3^Lupus,Erythematosus,Subacute Cutaneous
;;^UTILITY(U,$J,358.3,22916,1,4,0)
;;=4^L93.1
;;^UTILITY(U,$J,358.3,22916,2)
;;=^5009468
;;^UTILITY(U,$J,358.3,22917,0)
;;=M32.0^^76^987^19
;;^UTILITY(U,$J,358.3,22917,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22917,1,3,0)
;;=3^Lupus,Erythematosus,Drug-Induced Systemic
;;^UTILITY(U,$J,358.3,22917,1,4,0)
;;=4^M32.0
;;^UTILITY(U,$J,358.3,22917,2)
;;=^5011752
;;^UTILITY(U,$J,358.3,22918,0)
;;=M32.10^^76^987^22
;;^UTILITY(U,$J,358.3,22918,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22918,1,3,0)
;;=3^Lupus,Erythematosus,Systemic
;;^UTILITY(U,$J,358.3,22918,1,4,0)
;;=4^M32.10
;;^UTILITY(U,$J,358.3,22918,2)
;;=^5011753
;;^UTILITY(U,$J,358.3,22919,0)
;;=M32.19^^76^987^24
;;^UTILITY(U,$J,358.3,22919,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22919,1,3,0)
;;=3^Lupus,Erythematosus,Systemic,Skin Involvmnt
;;^UTILITY(U,$J,358.3,22919,1,4,0)
;;=4^M32.19
;;^UTILITY(U,$J,358.3,22919,2)
;;=^5011759
;;^UTILITY(U,$J,358.3,22920,0)
;;=M32.9^^76^987^23
;;^UTILITY(U,$J,358.3,22920,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22920,1,3,0)
;;=3^Lupus,Erythematosus,Systemic w/o Organ Involvmnt
;;^UTILITY(U,$J,358.3,22920,1,4,0)
;;=4^M32.9
;;^UTILITY(U,$J,358.3,22920,2)
;;=^5011761
;;^UTILITY(U,$J,358.3,22921,0)
;;=E88.1^^76^987^17
;;^UTILITY(U,$J,358.3,22921,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22921,1,3,0)
;;=3^Lipodystrophy NOS
;;^UTILITY(U,$J,358.3,22921,1,4,0)
;;=4^E88.1
;;^UTILITY(U,$J,358.3,22921,2)
;;=^5003028
;;^UTILITY(U,$J,358.3,22922,0)
;;=C85.19^^76^987^2
;;^UTILITY(U,$J,358.3,22922,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22922,1,3,0)
;;=3^B-Cell Lymphoma,Unspec,Extranodal/Solid Organ Sites
;;^UTILITY(U,$J,358.3,22922,1,4,0)
;;=4^C85.19
;;^UTILITY(U,$J,358.3,22922,2)
;;=^5001710
;;^UTILITY(U,$J,358.3,22923,0)
;;=C85.13^^76^987^5
;;^UTILITY(U,$J,358.3,22923,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22923,1,3,0)
;;=3^B-Cell Lymphoma,Unspec,Intra-Abdominal Lymph Nodes
;;^UTILITY(U,$J,358.3,22923,1,4,0)
;;=4^C85.13
;;^UTILITY(U,$J,358.3,22923,2)
;;=^5001704
;;^UTILITY(U,$J,358.3,22924,0)
;;=C85.16^^76^987^6
;;^UTILITY(U,$J,358.3,22924,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1F2 3794 printed Apr 09, 2024@21:54:56 Page 2
IBDEI1F2 ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,22912,0)
+2 ;;=L43.2^^76^987^16
+3 ;;^UTILITY(U,$J,358.3,22912,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,22912,1,3,0)
+6 ;;=3^Lichenoid Drug Reaction
+7 ;;^UTILITY(U,$J,358.3,22912,1,4,0)
+8 ;;=4^L43.2
+9 ;;^UTILITY(U,$J,358.3,22912,2)
+10 ;;=^5009180
+11 ;;^UTILITY(U,$J,358.3,22913,0)
+12 ;;=L43.9^^76^987^13
+13 ;;^UTILITY(U,$J,358.3,22913,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,22913,1,3,0)
+16 ;;=3^Lichen Planus,Unspec
+17 ;;^UTILITY(U,$J,358.3,22913,1,4,0)
+18 ;;=4^L43.9
+19 ;;^UTILITY(U,$J,358.3,22913,2)
+20 ;;=^5009183
+21 ;;^UTILITY(U,$J,358.3,22914,0)
+22 ;;=L93.0^^76^987^18
+23 ;;^UTILITY(U,$J,358.3,22914,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,22914,1,3,0)
+26 ;;=3^Lupus,Erythematosus,Discoid
+27 ;;^UTILITY(U,$J,358.3,22914,1,4,0)
+28 ;;=4^L93.0
+29 ;;^UTILITY(U,$J,358.3,22914,2)
+30 ;;=^5009467
+31 ;;^UTILITY(U,$J,358.3,22915,0)
+32 ;;=L93.2^^76^987^20
+33 ;;^UTILITY(U,$J,358.3,22915,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,22915,1,3,0)
+36 ;;=3^Lupus,Erythematosus,Local
+37 ;;^UTILITY(U,$J,358.3,22915,1,4,0)
+38 ;;=4^L93.2
+39 ;;^UTILITY(U,$J,358.3,22915,2)
+40 ;;=^5009469
+41 ;;^UTILITY(U,$J,358.3,22916,0)
+42 ;;=L93.1^^76^987^21
+43 ;;^UTILITY(U,$J,358.3,22916,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,22916,1,3,0)
+46 ;;=3^Lupus,Erythematosus,Subacute Cutaneous
+47 ;;^UTILITY(U,$J,358.3,22916,1,4,0)
+48 ;;=4^L93.1
+49 ;;^UTILITY(U,$J,358.3,22916,2)
+50 ;;=^5009468
+51 ;;^UTILITY(U,$J,358.3,22917,0)
+52 ;;=M32.0^^76^987^19
+53 ;;^UTILITY(U,$J,358.3,22917,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,22917,1,3,0)
+56 ;;=3^Lupus,Erythematosus,Drug-Induced Systemic
+57 ;;^UTILITY(U,$J,358.3,22917,1,4,0)
+58 ;;=4^M32.0
+59 ;;^UTILITY(U,$J,358.3,22917,2)
+60 ;;=^5011752
+61 ;;^UTILITY(U,$J,358.3,22918,0)
+62 ;;=M32.10^^76^987^22
+63 ;;^UTILITY(U,$J,358.3,22918,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,22918,1,3,0)
+66 ;;=3^Lupus,Erythematosus,Systemic
+67 ;;^UTILITY(U,$J,358.3,22918,1,4,0)
+68 ;;=4^M32.10
+69 ;;^UTILITY(U,$J,358.3,22918,2)
+70 ;;=^5011753
+71 ;;^UTILITY(U,$J,358.3,22919,0)
+72 ;;=M32.19^^76^987^24
+73 ;;^UTILITY(U,$J,358.3,22919,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,22919,1,3,0)
+76 ;;=3^Lupus,Erythematosus,Systemic,Skin Involvmnt
+77 ;;^UTILITY(U,$J,358.3,22919,1,4,0)
+78 ;;=4^M32.19
+79 ;;^UTILITY(U,$J,358.3,22919,2)
+80 ;;=^5011759
+81 ;;^UTILITY(U,$J,358.3,22920,0)
+82 ;;=M32.9^^76^987^23
+83 ;;^UTILITY(U,$J,358.3,22920,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,22920,1,3,0)
+86 ;;=3^Lupus,Erythematosus,Systemic w/o Organ Involvmnt
+87 ;;^UTILITY(U,$J,358.3,22920,1,4,0)
+88 ;;=4^M32.9
+89 ;;^UTILITY(U,$J,358.3,22920,2)
+90 ;;=^5011761
+91 ;;^UTILITY(U,$J,358.3,22921,0)
+92 ;;=E88.1^^76^987^17
+93 ;;^UTILITY(U,$J,358.3,22921,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,22921,1,3,0)
+96 ;;=3^Lipodystrophy NOS
+97 ;;^UTILITY(U,$J,358.3,22921,1,4,0)
+98 ;;=4^E88.1
+99 ;;^UTILITY(U,$J,358.3,22921,2)
+100 ;;=^5003028
+101 ;;^UTILITY(U,$J,358.3,22922,0)
+102 ;;=C85.19^^76^987^2
+103 ;;^UTILITY(U,$J,358.3,22922,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,22922,1,3,0)
+106 ;;=3^B-Cell Lymphoma,Unspec,Extranodal/Solid Organ Sites
+107 ;;^UTILITY(U,$J,358.3,22922,1,4,0)
+108 ;;=4^C85.19
+109 ;;^UTILITY(U,$J,358.3,22922,2)
+110 ;;=^5001710
+111 ;;^UTILITY(U,$J,358.3,22923,0)
+112 ;;=C85.13^^76^987^5
+113 ;;^UTILITY(U,$J,358.3,22923,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,22923,1,3,0)
+116 ;;=3^B-Cell Lymphoma,Unspec,Intra-Abdominal Lymph Nodes
+117 ;;^UTILITY(U,$J,358.3,22923,1,4,0)
+118 ;;=4^C85.13
+119 ;;^UTILITY(U,$J,358.3,22923,2)
+120 ;;=^5001704
+121 ;;^UTILITY(U,$J,358.3,22924,0)
+122 ;;=C85.16^^76^987^6
+123 ;;^UTILITY(U,$J,358.3,22924,1,0)
+124 ;;=^358.31IA^4^2
